P-270 Updated results of Maria Sklodowska-Curie National Research Institute of Oncology gastric cancer cohort: Indirect comparison between adjuvant chemoradiation and perioperative chemotherapy in gastric cancer patients

Abstract

Gastric cancer is associated with poor prognosis. Curative resection alone leads to a dismal outcome of gastric and GEJ adenocarcinoma. In the western gastric cancer patients are either treated with peri-operative chemotherapy or adjuvant chemoradiation. No direct comparisons of these two treatment strategies are available. In our referral gastric cancer center (NIO-PIB) we have changed in January 2013 the treatment protocol from adjuvant chemoradiation (like in INT-0116 study) to perioperative chemotherapy (ECF or CF regimen).